Published on 10 September 2021
Biosimilar epoetin for cancer and chemotherapy-induced anaemia in the US
DOI: 10.5639/gabij.2021.1003.015
2.411 views
Published on 10 September 2021
DOI: 10.5639/gabij.2021.1003.015
2.411 views
Published on 30 August 2021
biologicals, biosimilars, dermatology, psoriasis
DOI: 10.5639/gabij.2021.1003.018
6.085 views
Published on 30 August 2021
bioequivalence, COX-2 inhibitor, etoricoxib, generics
DOI: 10.5639/gabij.2021.1003.013
8.944 views
Published on 27 July 2021
Author(s): Michael S Reilly, Esq, Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP
biosimilars, Canada, policy, substitution, switching
DOI: 10.5639/gabij.2021.1003.016
8.347 views
Published on 22 June 2021
Author(s): Alfredo GarcÃa Arieta, PhD, Clare Rodrigues
DOI: 10.5639/gabij.2021.1003.019
3.668 views
Published on 22 June 2021
effectiveness, hand sanitizers, myths, regulatory framework, safety, standards
DOI: 10.5639/gabij.2021.1003.017
8.905 views
Published on 22 June 2021
1.644 views
Published on 21 May 2021
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2021.1002.011
2.601 views
Published on 20 May 2021
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2021.1002.005
3.010 views
Published on 09 March 2021
2.609 views
Published on 09 March 2021
1.759 views
Published on 23 February 2021
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2021.1001.001
2.694 views